Effectiveness and safety of the direct oral anticoagulant in acute distal deep vein thrombosis: From the prospective multicenter observational study, J'xactly, in Japan.

Makoto MoIkuo FukudaMashio NakamuraNorikazu YamadaMorimasa TakayamaHideaki MaedaTakeshi YamashitaTakanori IkedaTsutomu YamazakiYasuo OkumuraAtsushi Hirayamanull null

Published in: Phlebology (2022)

Short-term, low-dose rivaroxaban seems safe and effective for IDDVT treatment.

Keyphrases

low dose
venous thromboembolism
atrial fibrillation
liver failure
high dose
pulmonary embolism
respiratory failure
minimally invasive
cross sectional
drug induced
clinical trial
combination therapy
aortic dissection
hepatitis b virus
extracorporeal membrane oxygenation